Home » News » R&D Trends » FutureCeuticals opens bioclinical research facility

FutureCeuticals opens bioclinical research facility

Monday, March 12, 2012

FutureCeuticals, an R&D and manufacturing company of fruit, vegetable and grain-based products for the functional food and dietary supplement markets, has opened Applied BioClinical (ABC), a new bioclinical research facility in Irvine, Calif.

Using advanced clinical research tools and equipment, ABC is able to measure the acute and single-dose effect of products on a wide-range of biologically relevant targets, including a host of biomarkers associated with inflammation, aging, cardiovascular conditions and metabolic conditions and serum diagnostics, among others. The ABC testing paradigm allows for the time-efficient, affordable and publishable discoveries of new functions and mechanisms of action for tested products.

“The establishment of Applied BioClinical and our state-of-the-art facilities and clinical discovery research capabilities again demonstrates ongoing investment in and commitment to delivering unique, potent, market-leading ethical products and services,” said Dr. Zbigniew Pietrzkowski, chief science officer, and former vice president of R&D at FutureCeuticals. 

While Pietrzkowski and his team will continue to serve as the bioclinical R&D arm of FutureCeuticals, ABC provides a vehicle to make its bioclinical research expertise available to a wider audience within the scientific and business community and offer new opportunities for partnerships focused on co-discovery and product co-development.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!